Lung Cancers Today· @Lung_Cancers · X·· 4 小时前评分70
正文 · 原文
🌟 Behind the scenes at #ESMO26 with @FSkoulidis of @UTMDAnderson, who joined us for a fantastic interview on Krascendo 1!
➡️ Stay tuned for the interview and find more #ESMO2026 news here: https://buff.ly/6YOVI22
#lcsm #NSCLC #KRAS
7 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
Krascendo 3: A randomised, phase III trial in progress of divarasib vs immunotherapy or observation in patients with resected, stage II-IIIB, KRAS G12C+ non-small cell lung cancer
https://esmocongress.esmo.orgKRASCENDO-1
https://esmocongress.esmo.orgKRASCENDO-1
https://esmocongress.esmo.org来源：Lung Cancers Today · x.com